Skip to main content

European Medicines Agency

Question for Department for Exiting the European Union

UIN 5526, tabled on 17 July 2017

To ask the Secretary of State for Exiting the European Union, what assessment the Government has made of the effect on access to newly developed drugs and treatments of the UK ceasing to be a member of the European Medicines Agency.

Answered on

20 July 2017

We recognise the importance of a close cooperative relationship between the UK and EU in the field of medicines regulation and science and research collaboration.

As part of the negotiations the Government will discuss with the EU and Member States how best to continue cooperation in the field of medicines regulation in the best interests of business, citizens and patients in the UK and the EU.

Answered by

Department for Exiting the European Union
Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.